Skip to content

Endtidal Ethanol in Sclerotherapy

Endtidal Ethanol in Sclerotherapy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02740855
Enrollment
70
Registered
2016-04-15
Start date
2016-04-30
Completion date
2018-10-31
Last updated
2018-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ethanol Concentration

Keywords

sclerotherapy, ethanol, pulmonal hypertension

Brief summary

During the ethanol sclerotherapy procedure, the investigators will record doses of and time of ethanol injections and record ethanol concentrations in endtidal breath every 5 minutes. Furthermore after every ethanol injection the concentration will be measured every minute for 5 minutes. To do so, the investigators will attach a breath alcohol testing device to the expiratory carbon dioxide measuring unit. Since this is the new standard of the university hospital Berne all patients undergo the same procedure. There is no study specific intervention. In this study the investigators will only document the breath alcohol levels, doses and timing of ethanol injections. All other data will be obtained from the anesthesia information system. During the two months of the study, the investigators will also record endtidal ethanol concentration after anesthesia in the postoperative care unit discharge from the unit. The intention is to show the correlation between injected ethanol doses and measured endtidal ethanol concentration over the entire time of the intervention.

Interventions

DEVICEAlcomed 3011®

Endtidal ethanol measurement

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* undergoing ethanol sclerotherapy at the university hospital Berne

Exclusion criteria

* under the age of 18

Design outcomes

Primary

MeasureTime frame
Endtidal ethanol concentrations in mg/dl over time1 year 2 months

Secondary

MeasureTime frame
Bloodpressure in mmHg over time1 year 2 months
Bloodpressure in mmHg over injected peripheral ethanol volume1 year 2 months
Pulse rate in beats er minute over time1 year 2 months
Pulse rate in beats er minute over injected peripheral ethanol volume1 year 2 months
Endtidal ethanol concentrations in mg/dl over injected ethanol volume1 year 2 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026